Vaccine Delivery Devices Market Size, Share, Analysis 2032

Report Description

Vaccine Delivery Devices Market Outlook 2032

The global vaccine delivery devices market size was USD 7.1 Billion in 2023 and is projected to reach USD 14.08 Billion by 2032, expanding at a CAGR of 7.9% during 2024–2032. The market growth is attributed to the higher adoption rates of various vaccine delivery technologies.

Spurring demand for pediatric and geriatric vaccinations is resulting in the high utilization of vaccine delivery devices, which further boosts the market. Vulnerable age groups, including children and the elderly, require routine immunizations to prevent common and severe diseases. The aging global population and high birth rates in certain regions amplify the need for reliable and safe vaccination methods. Moreover, healthcare providers are increasingly using advanced delivery devices to ensure effective and painless vaccination processes for sensitive populations, further boosts the market in the coming years.

• As per the report released by the WHO on October 1, 2022, the worldwide population of people aged 60 and above is expected to increase to 2.1 billion by 2050.

Get Free Sample Report

Impact of Artificial Intelligence (AI) in Vaccine Delivery Devices Market

The use of artificial intelligence is likely to boost the vaccine delivery devices market. AI-powered devices assist healthcare professionals by automating dosing and administration processes. Additionally, AI facilitates personalized vaccination strategies by analyzing patient data to recommend optimal vaccination schedules and methods.

Vaccine Delivery Devices Market Dynamics

Get Free Sample Report

Major Drivers

Growing prevalence of infectious diseases is projected to boost the market. Outbreaks of diseases, such as influenza, hepatitis, and more recently, COVID-19, highlight the critical need for rapid and reliable vaccine administration. This trend is particularly significant in densely populated and low-income regions where the burden of infectious diseases is high. Consequently, healthcare systems are prioritizing the adoption of advanced delivery devices to improve immunization coverage and response times.

• According to the report published by the WHO on October 3, 2023, there are approximately one billion cases of seasonal influenza annually, with three to five million cases being severe.

Existing Restraints

Limited access to healthcare facilities is projected to hinder the market in the coming years. In rural and underserved areas, inadequate healthcare infrastructure limits the availability of vaccines and delivery devices. Poor transportation networks and storage facilities further complicate the distribution of these medical essentials. Furthermore, the high costs of advanced delivery devices further limit their ability to adapt and hamper the market.

Emerging Opportunities

­Ongoing technological advancements in vaccine delivery devices are expected to create immense opportunities for the players competing in the market. Manufacturers are integrating innovations, such as needle-free wearable injectors, microneedle patches, and automated delivery systems to offer improved patient comfort. These advancements also facilitate mass immunization efforts by enabling quicker and efficient vaccine administration. Furthermore, the Increasing adoption of smart delivery devices further boosts the market.

Scope of the Vaccine Delivery Devices Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Regional Outlook

In terms of region, the global vaccine delivery devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to the robust regulatory framework supporting the adoption of innovative vaccine delivery technologies.

The government's initiatives to improve immunization coverage and the public's strong health awareness contribute to the high utilization of these vaccine delivery systems. Additionally, the growing prevalence of chronic diseases requiring regular vaccinations further boosts the demand for advanced delivery devices in this region.

• According to the report published by the American Hospital Association, by 2030, the number of people suffering from chronic diseases is expected to reach 170 million.

The market in Asia Pacific is projected to grow at a significant pace in the years to come, owing to the large population bases and increasing government initiatives to expand immunization coverage. Countries, such as China and India are investing heavily in healthcare infrastructure and vaccination programs to combat infectious diseases. Additionally, the presence of numerous vaccine manufacturers and ongoing advancements in medical technology further propel the market in the coming years.

Get Free Sample Report

Vaccine Delivery Devices Market Segment Insights

Device Segment Analysis

Based on device, the vaccine delivery devices market is divided into jet injections, syringes, and others. The jet injections segment is expected to expand at a significant growth rate in the coming years, due to the rising demand for needle-free and pain-free vaccine administration methods.

Jet injectors use high-pressure streams to deliver vaccines through the skin, reducing the risk of needle-stick injuries and cross-contamination. Furthermore, growing awareness about their safety benefits and regulatory approvals for new jet injection products further boosts their demand.

Get Free Sample Report

Route of Administration Segment Analysis

On the basis of route of administration, the global market is segregated into intramuscular vaccination, intradermal vaccination, subcutaneous vaccination, and others. The intramuscular vaccination segment held largest market share in 2023, due to its widespread use and effectiveness in delivering a broad range of vaccines.

This route of administration is preferred for its ability to accommodate larger volumes of vaccine and its proven track record in inducing strong immune responses. Moreover, healthcare professionals are well-trained in this technique, which further boosts its prevalent use in vaccination campaigns.

The intradermal vaccination segment is anticipated to grow at a substantial CAGR during the forecast period, owing to its ability to use smaller doses while achieving similar or better immunogenic responses.

Intradermal vaccination is particularly advantageous for dose-sparing strategies, which is critical during vaccine shortages or pandemics. Additionally, the increasing interest in maximizing vaccine supply efficiency is likely to boost the adoption of intradermal vaccination.

Get Free Sample Report

End-user Segment Analysis

Based on end-user, the vaccine delivery devices market is segmented into clinics, hospitals, and others. The clinics segment is projected to register a robust growth rate during the assessment years, owing to their accessibility and increasing role in primary healthcare. Clinics offer convenient locations and flexible hours, making them an attractive option for routine vaccinations and public health initiatives.

The growing emphasis on preventive care and the expansion of community health services contribute to the rising importance of clinics in vaccine delivery. Furthermore, the technological advancements in portable vaccine delivery devices further facilitate their use in clinic settings, thereby fueling the market.